Miraz Rahman, a professor of medicinal chemistry at KCL, added: “If human trials are successful, KCL-HO-1i could become a ...

A groundbreaking cancer drug could enhance how patients respond to chemotherapy even in treatment-resistant tumours. A ...

A take-at-home tablet could boost the way cancer patients respond to chemotherapy, according to the medical experts who ...

Chronic diseases, such as cardiovascular ailments, diabetes, autoimmune disorders, and certain cancers, present a significant challenge to global public ...

An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...

There’s something truly special about being around horses and spending time in nature — and when you put the two together, the benefits are even greater. At Centaur Stride, we often take our lessons ...

To bolster your body's defenses against infections and chronic illnesses, incorporating nutrient-rich superfoods into your ...

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human ...

Discover the latest advancements in multiple sclerosis (MS) treatment, including innovative therapies and strategies for ...

Cells have evolved ingenious ways to defend themselves from viral attack. Research from The Wertheim UF Scripps Institute ...